Healthcare

MHRA highlights international coordination for healthcare AI

The UK’s MHRA expects AI to shape healthcare and is emphasizing international cooperation on safety signals, standards and regulation, including engagement with MENA.

The UK Medicines and Healthcare products Regulatory Agency is reported to expect AI to play a defining role in healthcare in the coming years. The article highlights regulatory efficiency and patient safety, with international cooperation identified as a way to develop shared safety signals and standards. The MHRA is also planning closer engagement with India and the Middle East and North Africa on AI-enabled healthcare. The development matters because clinical AI systems increasingly operate across jurisdictions, while regulatory requirements and safety-monitoring practices remain fragmented. Shared standards could help regulators evaluate AI tools more consistently and identify risks after deployment. The source presents cooperation through the Health AI Global Regulatory Network as part of this direction. It does not describe a specific AI product, clinical trial or newly approved medical device. Instead, it documents a regulatory trend toward international coordination, ongoing monitoring and closer engagement with regions adopting AI in health services. This could affect developers seeking to deploy diagnostic, monitoring or decision-support technologies in multiple markets.

Original source: EMJ Reviews

Related RAQI solutions

In-depth analysis on RAQI Insight

Work with RAQI